|
Market Closed -
Nasdaq
01:30:00 03/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.820 USD | 0.00% |
|
+1.39% | +58.26% |
| Market Cap | 81Cr 72Cr 67Cr 61Cr 115.44Cr 7.79TCr 116.52Cr 812.7Cr 314.92Cr 3.98TCr 304.05Cr 297.45Cr 13TCr | P/E 2026 * |
-10.7x | P/E 2027 * | -9.1x |
|---|---|---|---|---|---|
| Enterprise Value | 81Cr 72Cr 67Cr 61Cr 115.44Cr 7.79TCr 116.52Cr 812.7Cr 314.92Cr 3.98TCr 304.05Cr 297.45Cr 13TCr | EV / Sales 2026 * |
21.8x | EV / Sales 2027 * | 47.8x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LXRX | Delayed | |
CBOE
| LXRX | Real-time | |
|
Tradegate
| LX31 | Real-time |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 week | +1.39% | ||
| Current month | -2.93% | ||
| 1 month | -19.47% | ||
| 3 months | -21.55% | ||
| 6 months | +14.47% | ||
| Current year | +58.26% |
| 1 week | 1.8 |  | 2.05 |
| 1 month | 1.76 | | 2.25 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/06/26 | Exercice | Director | 1,78,624 | 0.0402% | ||
| 03/06/26 | Exercice | Director | 1,78,624 | 0.0402% | ||
| 03/06/26 | Exercice | Director | 1,78,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.39% | +29.08% | +75.00% | 81Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| -3.11% | -3.53% | +20.19% | +81.44% | 5.74TCr | |
| +0.89% | -0.63% | +2.17% | +36.19% | 4.76TCr | |
| +0.36% | +0.81% | +342.39% | +742.40% | 4.43TCr | |
| -0.96% | -4.50% | +24.96% | +35.38% | 4.25TCr | |
| -0.20% | -0.77% | +4.13% | +105.50% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +50.41% | 3.1TCr | |
| -2.68% | +2.92% | +29.33% | +22.72% | 2.85TCr | |
| +0.05% | -1.64% | -8.14% | -11.37% | 2.43TCr | |
| Average | -0.20% | -0.39% | +50.28% | +123.19% | 3.91TCr | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.90% | +138.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.72Cr 3.3Cr 3.08Cr 2.81Cr 5.3Cr 357.28Cr 5.35Cr 37Cr 14Cr 182.65Cr 14Cr 14Cr 586.18Cr | 1.69Cr 1.5Cr 1.4Cr 1.28Cr 2.41Cr 162.79Cr 2.44Cr 17Cr 6.59Cr 83Cr 6.36Cr 6.22Cr 267.09Cr |
| Net income | -7.38Cr -6.55Cr -6.12Cr -5.58Cr -11Cr -709.15Cr -11Cr -74Cr -29Cr -362.53Cr -28Cr -27Cr -1.16TCr | -9.7Cr -8.62Cr -8.05Cr -7.34Cr -14Cr -932.97Cr -14Cr -97Cr -38Cr -476.95Cr -36Cr -36Cr -1.53TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $1.820 | 0.00% | 23,17,716 |
| 01/26/01 | $1.820 | -2.93% | 22,73,032 |
| 30/26/30 | $1.875 | -0.27% | 17,44,199 |
| 29/26/29 | $1.880 | -1.05% | 39,46,250 |
| 28/26/28 | $1.900 | +5.85% | 1,08,93,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
